Analytical Data
-
基因名
CALB1
- Application
-
别名
(Calbindin D28)(D-28K)(Vitamin D-dependent calcium-binding protein, avian-type)
-
种属
Human
-
表达系统
E. coli
-
标签
N- His & C- Myc
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P05937
-
表达区间
2-261aa
-
分子量
37.3 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
S100G is a member of the S100 protein family, characterized by its EF-hand calcium-binding motif, which is crucial in various cellular processes such as cell growth, differentiation, and regulation of cytoskeletal dynamics. Research on S100G has gained significance due to its involvement in numerous physiological and pathological conditions, including cancer. Its expression is often dysregulated in tumor tissues, making it a potential biomarker for cancer diagnostics and a target for therapeutic interventions. Recent studies have focused on the structural and functional aspects of S100G, exploring its interactions with other proteins and its role in signaling pathways. This research aims to elucidate the molecular mechanisms underlying S100G's effects on tumor progression and to assess its potential as a therapeutic target. Additionally, recombinant S100G protein has been produced to facilitate these studies, enabling detailed investigations into its biochemical properties and functional roles in cellular contexts. Understanding the role of S100G in cancer and other diseases could pave the way for novel treatment strategies and improve diagnostic accuracy, highlighting the importance of ongoing research in this area.
